Tag: HEA OTC MTC PHA

Citius Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

CRANFORD, N.J. , July 8, 2025 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR) today announced that it has received...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Name

This field is for validation purposes and should be left unchanged.

HomeTagsHEA OTC MTC PHA

National Kidney Foundation and U.S. Pharmacy Organizations Call for Transition to Race-Agnostic eGFR in Medication Decision-Making

The Brothers That Just Do Gutters Launch BroGuard™, Architectural-Grade Gutter Protection Built for Real-World Performance

VINFAST’S GLOBAL REVENUE IN Q1 2026 INCREASED 42% YEAR OVER YEAR

Tag: HEA OTC MTC PHA

Citius Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us